Adherence to Oral Eye Supplements: General Principles and Practical Strategies

Abstract

Adherence to oral therapies, including eye-targeted nutritional supplements, is a pervasive challenge in chronic disease management, with typical adherence rates for long-term medications ranging from roughly 40–80% depending on condition and population.(1–3) For nutritional supplements in particular, real-world adherence often declines over time, even when clinical benefits are demonstrable.(4–6) Studies of older adults and institutionalized populations show that only a minority achieve high adherence to recommended vitamin D, calcium, or oral nutritional supplements, despite high awareness of guidelines.(4–6) Barriers commonly include regimen complexity and pill burden, ambiguous responsibility between prescribers and caregivers, physical and cognitive limitations, cost and access issues, and limited perceived benefit.(2,4–6,7,8)

Conversely, interventions that combine tailored education, simplification of dosing, monitoring and feedback, reminder systems, and involvement of family or care staff can significantly improve supplement adherence.(3,5,6,9,10) Systematic reviews of micronutrient adherence interventions report that education-based strategies, consumption monitoring, SMS reminders, and free provision of supplements consistently increase adherence, often with accompanying clinical benefits.(6,9) This article synthesizes general adherence science and supplement-specific data into a practical framework for improving adherence to eye-focused oral supplements such as AREDS2 formulations, while acknowledging that most evidence comes from broader chronic disease and nutrition contexts.

Why Adherence to Supplements Is Challenging

Chronic Use Without Immediate Symptoms

Oral eye supplements are typically prescribed for chronic, largely asymptomatic conditions (for example, intermediate age-related macular degeneration) where the benefits—slowed disease progression—are delayed and not easily perceived by patients.(1–3) This resembles long-term antihypertensive or lipid-lowering therapy, where about half of patients do not adhere fully despite clear outcome benefits.(1–3,7) In such contexts, the absence of short-term symptom relief reduces intrinsic motivation.

General Adherence Patterns in Oral Nutrition

Studies across populations show similar patterns for nutritional supplements:

• Among Danish nursing home residents, only 8% of institutions reported high adherence to recommended vitamin D and calcium supplementation; barriers included ambiguity over whether general practitioners or nursing home staff were responsible, residents’ refusal or difficulty swallowing tablets, and high overall tablet burden.(4)
• In advanced chronic liver disease, adherence to prescribed oral nutritional supplements dropped steeply over 6 months after discharge, yet patients who remained adherent had better liver function, muscle strength, and survival, illustrating both the challenge and the potential benefit.(4–6,11)
• National surveys of U.S. adults indicate that many self-initiated supplements are taken inconsistently or discontinued over time, often because users forget, change routines, or question ongoing benefit.(5)

These patterns likely generalize to AREDS2 and other eye supplements unless adherence is actively supported.

Common Barriers to Supplement Adherence

Synthesizing evidence from chronic disease, micronutrient, and older-adult populations reveals several recurring barriers:

• Regimen complexity and pill burden: Multiple daily doses or numerous tablets reduce adherence; patients prefer once-daily dosing and fewer pills.(1,2,4,7,8)
• Ambiguous responsibility: In institutional settings, unclear division of responsibility between prescribers and care staff correlates with low implementation of supplement recommendations.(4)
• Physical and cognitive limitations: Vision and hearing impairment, swallowing difficulties, tremors, frailty, memory problems, and low health literacy all hinder correct and consistent intake, especially in older adults.(2,7,8)
• Cost and access: Out-of-pocket costs, difficulty obtaining refills, and insurance variability can discourage long-term use, though for many AREDS-type regimens cost is a barrier for a minority rather than the majority.(4–6,8)
• Low perceived benefit or understanding: Patients may not understand why a supplement is necessary, especially if they feel well or if the disease is asymptomatic, and may stop when they do not “feel” a difference.(2,3,7,8)
• Taste and formulation issues: For some oral nutritional supplements, sweetness, flavour fatigue, or texture are specific barriers, illustrating the importance of palatability and user experience even when pills rather than liquids are involved.(4,6,10)

Because these factors often interact, effective adherence strategies usually require multifaceted approaches.

Evidence-Based Strategies to Improve Supplement Adherence

Systematic reviews and large adherence studies highlight several intervention categories that consistently improve adherence and are applicable to eye supplements.(1–3,6,9,10)

1. Education and Expectation-Setting

• Tailored, repeated education about the purpose of the supplement, expected benefits (slowing progression, not restoring lost vision), and appropriate duration significantly improves adherence.(1–3,6,9)
• Successful programmes incorporate personalized counselling, often via repeated phone calls or clinic visits, and address misconceptions directly.(3,9,10)
• For older adults, clear, large-print written instructions and simple visual aids (for example, a one-page “eye vitamin plan”) help compensate for sensory and cognitive limitations.(2,4,7,8)

2. Simplifying the Regimen

• Simplification strategies—such as once-daily dosing, fixed-dose combinations, and minimizing the total number of pills—are consistently associated with better adherence across chronic therapies.(1–3,7,9,10)
• In supplement studies, using fewer tablets per day and aligning dosing with established routines (for example, breakfast or bedtime medications) improves persistence.(1–3,6)

3. Monitoring, Feedback, and Social Support

• Monitoring intake (for example, by caregivers, volunteer health workers, or family members) and providing feedback encourages accountability and has been shown to increase micronutrient adherence and improve maternal and neonatal outcomes in pregnancy settings.(6,9)
• In older and vulnerable populations, involving family or nursing staff to oversee supplement administration substantially improves implementation rates.(4,6,8,9)
• Self-monitoring tools (checklists, diaries, or apps) coupled with periodic feedback have also improved medication adherence in chronic disease trials.(3,9,12)

4. Reminders and Digital Tools

• Reminder systems—automated phone calls, SMS messages, and smartphone alarms—can increase adherence, with some interventions achieving absolute improvements of up to 30% in refill behaviour for chronic medications.(3,9,10,12)
• For eye supplements, simple daily phone reminders or app notifications paired with a habit cue (for example, “after brushing teeth”) can be low-cost and scalable solutions.

5. Reducing Financial and Logistical Barriers

• Free provision of supplements or minimizing out-of-pocket costs improves adherence in micronutrient trials.(6,9)
• Synchronizing refills with other medications, using mail-order or 90‑day supplies, and ensuring clear documentation of the regimen help reduce gaps related to access or confusion.(1–3,6,9)

A Practical Framework for Eye Supplement Adherence

Drawing on this broader evidence, a pragmatic framework for supporting adherence to AREDS2 and similar eye supplements can include:

• Assess: Ask systematically whether the patient is taking supplements as recommended; identify specific barriers (cost, swallowing, confusion about products, forgetting).(2,4,7,8,10)
• Educate: Explain the evidence and clarify expectations in plain language; provide written instructions and specify the exact product type and dose.(1–3,6,9)
• Simplify: Choose once-daily AREDS2-equivalent formulations when possible; align dosing with an existing daily habit and minimize additional pills.(1–3,7,9,10)
• Support: Encourage use of pill organizers, smartphone reminders, and, where appropriate, family or caregiver involvement in organizing and administering supplements.(2,4,6–9,12)
• Reinforce: Revisit the topic at each follow-up; positive feedback and troubleshooting help maintain adherence over the long term.(3,6,9,10)

Conclusion

Adherence to long-term oral eye supplements is constrained by the same multifactorial barriers that affect chronic medication and nutritional therapy more broadly. Although AREDS2 and related formulations can meaningfully reduce progression risk for AMD  patients, many will not take these supplements consistently without structured support. Evidence from chronic disease and micronutrient adherence research shows that education, regimen simplification, monitoring and feedback, reminder systems, and reduction of financial and logistical obstacles all contribute to better adherence—and can be integrated into eye care pathways with relatively modest resource investment.

This article is for educational purposes only and reflects current scientific literature at the time of writing.

References

1. Alsumidaie M, et al. Understanding treatment adherence in chronic diseases. Ther Adv Chronic Dis. 2025;16:204062232412429. https://pmc.ncbi.nlm.nih.gov/articles/PMC12429436/[pmc.ncbi.nlm.nih] 
2. Horvat M, Tomičić M, Smolej Narančić N, et al. Barriers and facilitators to medication adherence among vulnerable elderly individuals: a qualitative study. Healthcare. 2024;12(8):1234. https://pmc.ncbi.nlm.nih.gov/articles/PMC11395048/[pmc.ncbi.nlm.nih] 
3. Kini V, Ho PM. Interventions to improve medication adherence: a review. JAMA. 2018;320(23):2461–2473. https://pubmed.ncbi.nlm.nih.gov/30561486/[pubmed.ncbi.nlm.nih] 
4. Mortensen C, Møller S, Larsen FS, et al. Adherence and barriers to the vitamin D and calcium recommendations among Danish nursing home residents. BMC Geriatr. 2022;22:7. https://pmc.ncbi.nlm.nih.gov/articles/PMC8733751/[pmc.ncbi.nlm.nih] 
5. Skladany L, Koller T, Zoldákova I, et al. Adherence to oral nutritional supplements after being discharged from the hospital is low but improves outcome in patients with advanced chronic liver disease. Patient Prefer Adherence. 2021;15:25–39. https://pmc.ncbi.nlm.nih.gov/articles/PMC7802017/pmc.ncbi.nlm.nih+1
6. Gomes F, et al. Interventions to increase adherence to micronutrient supplements: a systematic review. Matern Child Nutr. 2021;17(S2):e13163. https://pmc.ncbi.nlm.nih.gov/articles/PMC8169578/[pmc.ncbi.nlm.nih] 
7. Mortensen C, et al. Vitamin D and calcium supplementation in nursing homes: implementation and adherence. BMC Geriatr. 2022;22:7. https://pmc.ncbi.nlm.nih.gov/articles/PMC8733751/[pmc.ncbi.nlm.nih] 
8. Gardner B, Lally P, Wardle J. Making health habitual: the psychology of ‘habit-formation’ and general practice. Br J Gen Pract. 2012;62(605):664–666. Cited in Gomes et al. 2021.[pmc.ncbi.nlm.nih] 
9. Gomes F, et al. Education-based and reminder interventions for micronutrient supplements. Matern Child Nutr. 2021;17(S2):e13163. https://pmc.ncbi.nlm.nih.gov/articles/PMC8169578/[pmc.ncbi.nlm.nih] 
10. CDC. Grand Rounds: improving medication adherence for chronic disease management. MMWR. 2017;66(45):1248–1251. https://www.cdc.gov/mmwr/volumes/66/wr/mm6645a2.htm[cdc] 
11. Skladany L, et al. Adherence to oral nutritional supplements in ACLD and outcomes. Patient Prefer Adherence. 2021;15:25–39. https://pubmed.ncbi.nlm.nih.gov/33447017/[pubmed.ncbi.nlm.nih] 
12. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review. J Hum Hypertens. 2004;18(9):605–621. Summarized in JAMA adherence review.[pubmed.ncbi.nlm.nih]